(Q41821940)

12 October 2017

0 references

Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis (English)

1 reference

12 October 2017

1 reference

1 reference

1 reference

Rodger M

1

1 reference

12 October 2017

Bredeson C

2

1 reference

12 October 2017

Wells PS

3

1 reference

12 October 2017

Beck J

4

1 reference

12 October 2017

Kearns B

5

1 reference

12 October 2017

Huebsch LB

6

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Canadian Medical Association Journal

12 October 2017

1 reference

12 October 2017

159

1 reference

12 October 2017

8

1 reference

12 October 2017

931-938

1 reference

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Low molecular weight heparin

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229738

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9834718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9834718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

12 October 2017

PubMed publication ID

9834718

1 reference